• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2009 Norwegian Knowledge Centre for the Health Services (NOKC) [Methylnaltrexone for opioid-induced constipation in cancer treatment]
2009 Norwegian Knowledge Centre for the Health Services (NOKC) Effectiveness of interventions designed to reduce the prevalence of female genital mutilation/cutting
2009 Norwegian Knowledge Centre for the Health Services (NOKC) [Laparoscopic surgery for benign gynaecological disease]
2009 Norwegian Knowledge Centre for the Health Services (NOKC) [The effect of rehabilitation on social and community participation]
2009 Norwegian Knowledge Centre for the Health Services (NOKC) [The scientific knowledge base for treatment of patients with cleft lip, alveolus and palate]
2009 Norwegian Knowledge Centre for the Health Services (NOKC) [Effect of certification and accreditation of hospitals]
2009 Norwegian Knowledge Centre for the Health Services (NOKC) [Cost-effectiveness of childhood vaccination against rotavirus in Norway]
2009 Blue Cross Blue Shield Association (BCBS) Special report: vaccines for the treatment of prostate cancer
2009 Blue Cross Blue Shield Association (BCBS) Percutaneous vertebroplasty or kyphoplasty for vertebral fractures caused by osteoporosis
2009 Blue Cross Blue Shield Association (BCBS) Cardiac resynchronization therapy for mild congestive heart failure
2009 Blue Cross Blue Shield Association (BCBS) Accelerated radiotherapy after breast-conserving surgery for early stage breast cancer
2009 Blue Cross Blue Shield Association (BCBS) Special report: laboratory testing to allow area under the curve (AUC) - targeted 5-Fluorouracil dosing for patients administered chemotherapy for cancer
2009 Blue Cross Blue Shield Association (BCBS) Genetic testing for predisposition to inherited hypertrophic cardiomyopathy
2009 Blue Cross Blue Shield Association (BCBS) Angioplasty and stenting of the cervical carotid artery with embolic protection of the cerebral circulation
2009 Blue Cross Blue Shield Association (BCBS) Pharmacogenetic testing to predict serious toxicity from 5-Fluorouracil (5-FU) for patients administered 5-FU-based chemotherapy for cancer
2009 Quality Improvement Scotland (NHS QIS ) Is patient self-monitoring (including self-testing and selfmanagement) of oral anticoagulation therapy safe, efficacious and cost-effective?
2009 Quality Improvement Scotland (NHS QIS ) Provision of information to patients with long term conditions
2009 Quality Improvement Scotland (NHS QIS ) A systematic narrative review of quality improvement models in health care
2009 Quality Improvement Scotland (NHS QIS ) Clinical and cost-effectiveness of self-monitoring of blood glucose (SMBG) for non-insulin treated type 2 diabetes
2009 West Midlands Health Technology Assessment Collaboration (WMHTAC) A systematic review of lesbian, gay, bisexual and transgender health in the West Midlands region of the UK compared to published UK research
2009 VA Technology Assessment Program (VATAP) Circulator boot for lower limb vascular insufficiency
2009 VA Technology Assessment Program (VATAP) Screening for oral cancer
2009 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Repetitive Transcranial Magnetic Stimulation (rTMS)]
2009 Basque Office for Health Technology Assessment (OSTEBA) [Validation of an assessment scale of the risk of pressure ulcers in hospitalized children]
2009 Basque Office for Health Technology Assessment (OSTEBA) [The coordination between primary and specialized healthcare from the point of view of the professionals]
2009 Basque Office for Health Technology Assessment (OSTEBA) [Group monitoring of psychotic patients in the public health network of the Basque Autonomous Community]
2009 Basque Office for Health Technology Assessment (OSTEBA) [Study of urgent and emergency health services in the Basque Autonomous Community: analysis and proposals for improvement]
2009 Basque Office for Health Technology Assessment (OSTEBA) [Health impact assessment of the Integral Regeneration Plan of Uretamendi-Betolaza and beltway]
2009 Basque Office for Health Technology Assessment (OSTEBA) [Confidentiality of medical records. Analysis of the current situation and areas for improvement in their use and management]
2009 Basque Office for Health Technology Assessment (OSTEBA) [Analysis of the adequacy of diagnostic indications of the following application techniques of cerebral MR: MR spectroscopy, diffusion, gadolinum perfusion and cerebral functional-activation MR in advanced neurological diagnosis]
2009 Basque Office for Health Technology Assessment (OSTEBA) [Improving the care of elderly patients with chronic pathologies]
2009 Institute for Clinical Evaluative Sciences (ICES) Blood glucose test strip use: patterns, costs and potential cost reduction associated with reduced testing
2009 Institute for Clinical Evaluative Sciences (ICES) What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2009 Institute for Clinical Evaluative Sciences (ICES) Registry of the Canadian Stroke Network. Report on the 2004/05 Ontario Stroke Audit
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [BRATS 10: Rituximab in the treatment of diffuse large B-cell non-Hodgkin's lymphoma (DLBCL)]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [BRATS 09: Statins for the prevention of cardiovascular events]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [BRATS 08: Drug-eluting stents and bare-metal stents in the treatment of coronary artery disease]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) BRATS 07: Deferasirox for the treatment of iron overload
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of natriuretic peptides for diagnosing cardiac insufficiency in patients with acute dyspnea]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of malignant melanoma]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of esophageal cancer]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of malignant lymphoma]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Alteplase (rt-PA) in the cerebral vascular ischemic accident]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of breast cancer]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of colon and rectal cancer]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of polyglycolic polymerized matrix artery graft]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Positron Emission Tomography (PET) in the diagnosis, staging and re-staging of head and neck cancers]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of radiofrequency ablation in the surgical treatment of atrial fibrillation]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of basal action recombinant insulin, analogous to human insulin, (glargine and determir) for treating type 1 diabetes mellitus]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of paliperidone for treating schizophrenia]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of rituximabe in treating B-cell non-hodgkin's lymphoma, low-grade CD 20]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of the artery protection system Embol-X]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of lithium dilution systems for monitoring cardiac output: comparison with available alternatives]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of Bortezomib in treating refractory multiple myeloma]
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of everolimus to prevent renal transplant rejection]
2009 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in CHF management programmes. Organizational challenges and evidence status]
2009 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in mental health (Telepsychiatry)]
2009 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Physical disease in schizophrenia: systematic review and analysis of hospital records]
2009 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Transient elastography (Fibroscan) for the diagnosis of liver fibrosis: a systematic review and meta-analysis]
2009 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [The effectiveness of Positron Emission Tomography (PET) with 18FDG in breast cancer. A systematic review and meta-analysis]
2009 Gesundheit Osterreich GmbH (GOeG) [Professional dental prophylaxis]
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Nonmedical secondary prevention of patients with coronary heart disease]
2009 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Arthroplasty register for Germany]
2009 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Pumpless extracorporeal lung assist device (Novalung)
2009 Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2009 Penn Medicine Center for Evidence-based Practice (CEP) Managing the difficult airway
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for intermediate risk factors for coronary heart disease: systematic evidence synthesis
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for bilirubin encephalopathy
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in older adults: systematic review to update the 1996 U.S. Preventive Services Task Force recommendation
2009 Agency for Healthcare Research and Quality (AHRQ) Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for child and adolescent depression in primary care settings: a systematic evidence review for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Evaluating test strategies for colorectal cancer screening - age to begin, age to stop, and timing of screening intervals: a decision analysis of colorectal cancer screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET).
2009 NIHR Health Technology Assessment programme Mifamurtide for osteosarcoma
2009 NIHR Health Technology Assessment programme Tocilizumab for the treatment of rheumatoid arthritis
2009 NIHR Health Technology Assessment programme Erlotinib for the treatment of relapsed non-small cell lung cancer
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Topical diclofenac for the treatment of musculoskeletal pain unrelated to osteoarthritis: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Pyxis and medDISPENSE automated medication dispensing systems: a review of the clinical benefits and harms, cost-effectiveness, and guidelines for use
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological management of depression in Parkinson's disease: evidence for antidepressant of choice
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological interventions for weight loss: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Oxybutynin, tolterodine, and darifenacin: review of cognitive adverse events
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared to fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: supplementary analyses relating to risk of infection from an unknown virus
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) n-3 lipids for patients on total parenteral nutrition: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Minimal access lobectomy for lung cancer patients: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical testing in colorectal cancer screening of average risk individuals: economic evaluation
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography for pediatric patients: review of clinical effectiveness and indications for use
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins: review of the comparative effectiveness for various indications
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Specialty mattresses for the prevention and management of pressure ulcers: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Benzodiazepines for the treatment of post traumatic stress disorder: a review of the clinical effectiveness and guidelines